The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world outcome analysis of patients with advanced gastric and gastroesophageal adenocarcinoma with HER2-low expression treated with first-line therapy.
 
Mary Frances Mulcahy
Consulting or Advisory Role - Boston Scientific
Research Funding - BTG
 
Halla Nimeiri
Employment - Northwestern Medicine; Tempus
Stock and Other Ownership Interests - Abbvie; Roche
 
Osama E. Rahma
Employment - AstraZeneca/MedImmune; Outcomes4me
Leadership - AstraZeneca/MedImmune; Outcomes4me
Stock and Other Ownership Interests - AstraZeneca/MedImmune; Outcomes4Me
Honoraria - Alaunus Global; Clinical Care Options; Leerink; Merck; MI Bioresearch; PRMA Consulting
Consulting or Advisory Role - Alcimed; Bayer; Celgene; Defined Health; Five Prime Therapeutics; Genentech; Gfk; GlaxoSmithKline; Imvax; Leerink; Leerink; Maverick Therapeutics; Merck; PureTech; Putnam Associates; Sobi
Research Funding - Amgen (Inst); Merck
Patents, Royalties, Other Intellectual Property - PD-1/PD-L1 (Inst); Pending patent (DFCI 2386.010) (Inst)
Travel, Accommodations, Expenses - Clinical Care Options; Genentech; Merck; PRMA Consulting; PureTech
 
Jonathan Wills
Employment - Tempus
Stock and Other Ownership Interests - Tempus
 
Kristian Del Rosario
Employment - Tempus
Stock and Other Ownership Interests - Tempus
 
Justin Lien
Employment - Tempus
Stock and Other Ownership Interests - Johnson & Johnson/Janssen; Tempus
 
Raphael Pelossof
Employment - Tempus
Stock and Other Ownership Interests - Tempus
Patents, Royalties, Other Intellectual Property - We have applied for patents for some of the technologies that pertain to RNA normalization. (Inst)
Travel, Accommodations, Expenses - Tempus
 
Talal Ahmed
Employment - Tempus
Stock and Other Ownership Interests - Tempus
Patents, Royalties, Other Intellectual Property - I am co-author for a pending patent that is sponsored by Tempus Labs Inc.
 
Justin Guinney
Employment - Tempus
Consulting or Advisory Role - AstraZeneca
Research Funding - AstraZeneca (Inst); Bristol Meyers Squib (Inst); Roche/Genentech (Inst)
 
Nike Beaubier
Employment - Tempus
Stock and Other Ownership Interests - Tempus
 
Filippo Pietrantonio
Honoraria - Amgen; AstraZeneca/MedImmune; Bayer; Lilly; MSD Oncology; Sanofi; SERVIER
Consulting or Advisory Role - Amgen; Merck; MSD Oncology; SERVIER
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst)
 
Yoshiaki Nakamura
Honoraria - Chugai Pharma; Guardant Health AMEA; Merck
Research Funding - Chugai Pharma (Inst); Genomedia (Inst); Guardant Health (Inst); Guardant Health (Inst); Roche (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst)
 
Iker Huerga
Employment - AstraZeneca; Memorial Sloan-Kettering Cancer Center; Tempus
Stock and Other Ownership Interests - Tempus
Consulting or Advisory Role - AstraZeneca
 
Takayuki Yoshino
Honoraria - Bayer Yakuhin; Chugai Pharma; Merck; MSD K.K.; Ono Pharmaceutical
Research Funding - Amgen (Inst); Chugai Pharma (Inst); DAIICHI SANKYO COMPANY, LIMITED (Inst); Genomedia (Inst); MSD (Inst); Nippon Boehringer Ingelheim (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Sanofi (Inst); Sysmex (Inst); Taiho Pharmaceutical (Inst)